UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 30, 2007
 
TOMOTHERAPY INCORPORATED
(Exact name of registrant as specified in its charter)
Wisconsin
(State or other jurisdiction of incorporation)
     
001-33452
(Commission File Number) 		  39-1914727
(IRS Employer Identification No.)
     
1240 Deming Way
Madison, Wisconsin
(Address of principal executive offices) 		  53717
(Zip Code)
(608) 824-2800
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 2.02. Results of Operations and Financial Condition.
On October 30, 2007, TomoTherapy Incorporated (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2007. A copy of the Company’s press release dated October 30, 2007, titled “TomoTherapy Reports Third Quarter Financial Results” is attached hereto as Exhibit 99.1.
Exhibit 99.1 contains forward-looking statements within the meaning of the federal securities laws. These statements are present expectations, and are subject to the limitations listed therein and in the Company’s other reports filed with the Securities and Exchange Commission, including that actual events or results may differ materially from those in the forward-looking statements.
The foregoing information (including the exhibit hereto) is being furnished under “Item 2.02 Results of Operations and Financial Condition” (including the exhibit hereto) and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
     (d) Exhibits.
     
Number   Description
99.1
  Press Release dated October 30, 2007, titled “TomoTherapy Reports Third Quarter Financial Results”

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  TOMOTHERAPY INCORPORATED
  		 
Dated: October 30, 2007  By:   /s/ Stephen C. Hathaway    
    Stephen C. Hathaway   
    Chief Financial Officer    

 

 

         
EXHIBIT INDEX
     
Number   Description
99.1
  Press Release dated October 30, 2007, titled “TomoTherapy Reports Third Quarter Financial Results”

 

Tomotherapy Incorporated (MM) (NASDAQ:TTPY)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Tomotherapy Incorporated (MM) Charts.
Tomotherapy Incorporated (MM) (NASDAQ:TTPY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Tomotherapy Incorporated (MM) Charts.